Sodium valproate inhibits glucose transport and exacerbates Glut1-deficiency in vitro

Journal of Cellular Biochemistry

Volumn 96, Issue 4, 2005, Pages 775-785

  Wong, Hei Yi ^a   Chu, Tsui Shan ^a   Lai, Janice Ching ^a   Fung, Kwok Pui ^a   Fok, Tai Fai ^a   Fujii, Tatsuya ^b   Ho, Yuan Yuan ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHIGA MEDICAL CENTER FOR CHILDREN   (Japan)

Author keywords

Anticonvulsant; Epilepsy; Glucose; Glut1; Glut1 deficiency syndrome; Sodium valproate

Indexed keywords

ANTICONVULSIVE AGENT; GLUCOSE TRANSPORTER 1; VALPROIC ACID;

ANIMAL CELL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL TRANSPORT; CONTROLLED STUDY; DISEASE EXACERBATION; ERYTHROCYTE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT SYSTEM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SKIN FIBROBLAST;

ANIMALS; ASTROCYTES; BIOLOGICAL TRANSPORT; CELLS, CULTURED; ERYTHROCYTES; FIBROBLASTS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GUANOSINE; HUMANS; KINETICS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS; VALPROIC ACID;

ANIMALIA;

EID: 27644531002     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20555     Document Type: Article

References (47)

1. Bolanos JP, Medina JM. 1997. Effect of valproate on the metabolism of the central nervous system. Life Sci 60:1933-1942.
2. Brown GK. 2000. Glucose transporters: Structure, function and consequences of deficiency syndrome: Impaired glucose transport into brain-A review. Eur J Pediatr 161:295-304.
3. Caviglia D, Scarabelli L, Palmero S. 2004. Effects of carnitines on rat sertoli cell protein metabolism. Horm Metab Res 36:221-225.
4. Chang RC, Stadlin A, Tsang D. 2001. Effects of tumor necrosis factor alpha on taurine uptake in cultured rat astrocytes. Neurochem Int 38:246-254.
5. Davis R, Peters DH, McTavish D. 1994. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs 47:332-372.
6. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI, 1991. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325:703-709.
7. De Vivo DC, Leary L, Wang D. 2002a. Glucose transporter 1 deficiency syndrome and other glycolytic defects. J Child Neurol 17:3815-3823.
8. De Vivo DC, Wang D, Pascual JM, Ho YY. 2002b. Glucose transporter protein syndromes. Int Rev Neurobiol 51:259-288.
9. Drewes LR. 1998. Biology of the blood-brain glucose transporter. In: Pardridge WM, editors, Introduction to the blood-brain barrier, Cambridge: Cambridge University Press, pp 165-187.
10. Duelli R, Kuschinsky W. 2001. Brain glucose transporters: Relationship to local energy demand. News Physiol Sci 16:71-76.
11. Ebbesen F, Joergensen A, Hoseth E, Kaad PH, Moeller M, Holsteen V, Rix M. 2000. Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate. Arch Dis Child Fetal Neonatal Ed 83:F124-F129.
12. Fujii T, Ho YY, Wang D, De Vivo DC, Kohama M, Miyajima T, Ikuno N, Wong HY, Ito M. 2005. Two Japanese patients with the glucose transporter type 1 deficiency syndrome (abstract). Epilepsia 46(suppl. 3):13.
13. Hiraki Y, Rosen OM, Birnbaum MJ. 1988. Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem 263:13655-13662.
14. Ho YY, Yang H, Klepper J, Fischbarg J, Wang D, De Vivo DC. 2001. Glucose transporter type 1 deficiency syndrome (Glut1DS): Methylxanthines potentiate GLUT1 haplosufficiency in vitro. Pediatr Res 50:254-260.
15. Ho YY, Wang D, De Vivo DC. 2002. Glucose transporters, in Wiley encyclopedia of molecular medicine, New York: John Wiley & Sons, Inc., pp 1441-1446.
16. Honkanen RA, McBath H, Kushmerick C, Callender GE, Scarlata SF, Fenstermacher JD, Haspel HC. 1995. Barbiturates inhibit hexose transport in cultured mammalian cells and human erythrocytes and interact directly with purified GLUT-1. Biochemistry 34:535-544.
17. Hruz PW, Mueckler MM. 2001. Structural analysis of the GLUT1 facultative glucose transporter (review). Mol Membr Biol 18:183-193.
18. Hu XJ, Peng F, Zhou HQ, Zhang ZH, Cheng WY, Feng HF. 2000. The abnormality of glucose transporter in the erythrocyte membrane of Chinese type 2 diabetic patients. Biochim Biophys Acta 1466:306-314.
19. Johannessen CU, Petersen D, Fonnum F, Hassel B. 2001. The acute effect of valproate on cerebral energy metabolism in mice. Epilepsy Res 47:247-256.
20. Joost HG, Bell GI, Best JD, Birnbaum MJ, Charron MJ, Chen YT, Doege H, James DE, Lodish HF, Moley KH, Moley JF, Mueckler M, Rogers S, Schurmann A, Seino S, Thorens B. 2002. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab 282:E974-E976.
21. Kalaria RN, Harik SI. 1989. Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J Neurochem 53:1083-1088.
22. Kalaria EN, Gravina SA, Schmidley JW, Perry G, Harik SI. 1988. The glucose transporter of the human brain and blood-brain barrier. Ann Neurol 24:757-764.
23. Kessel A, Musafia B, Ben-Tal N. 2001. Continuum solvent model studies of the interactions of an anticonvulsant drug with a lipid bilayer. Biophys J 80:2536-2545.
24. Klepper J, Voit T. 2002. Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: Impaired glucose transport into brain-A review. Eur J Pediatr 161:295-304.
25. Klepper J, Garcia-Alvarez M, O'Driscoll KR, Parides MK, Wang D, Ho YY, De Vivo DC. 1999a. Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome. J Clin Lab Anal 13:116-121.
26. Klepper J, Fischbarg J, Vera JC, Wang D, De Vivo DC. 1999b. GLUT1-deficiency: Barbiturates potentiate haplosufficiency in vitro. Pediatr Res 46:677-683.
27. Klepper J, Florcken A, Fischbarg J, Voit T. 2003. Effects of anticonvulsants on GLUT1-mediated glucose transport in GLUT1 deficiency syndrome in vitro. Eur J Pediatr 162:84-89.
28. Krauss SW, Diamond I, Gordon AS. 1994. Selective inhibition by ethanol of the type 1 facilitative glucose transporter (GLUT1). Mol Pharmacol 45:1281-1286.
29. Leiderman DB, Balish M, Bromfield EB, Theodore WH. 1991. Effect of valproate on human cerebral glucose metabolism. Epilepsia 32:417-422.
30. ΔΔCT method. Method 25:402-408.
31. Lowe AG, Walmsley AR. 1986. The kinetic of glucose transport in human red blood cells. Biochim Biophys Acta 857:146-154.
32. Mesmer OT, Lo TC. 1990. Hexose transport properties of myoblasts isolated from a patient with suspected muscle carnitine deficiency. Biochem Cell Biol 68:1372-1379.
33. Miele C, Formisano PM, Condorelli G, Caruso M, Oriente F, Andreozzi F, Tocchetti CG, Riccardi G, Beguinot F. 1997. Abnormal glucose transport and GLUT1 cell surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Diabetologia 40:421-429.
34. Motais R, Baroin A, Motais A, Baldy S. 1980. Inhibition of anion and glucose permeabilities by anesthetics in erythrocytes. Biochim Biophys Acta 599:673-688.
35. Nagamatsu S, Nakamichi Y, Inoue N, Inoue M, Nishino H, Sawa H. 1996. Rat C6 glioma cell growth is related to glucose transport and metabolism. Biochem J 319:477-482.
36. Pardridge WM, Boado RJ. 1993. Molecular cloning and regulation of gene expression of blood-brain barrier glucose transporter. In: Pardridge W.M. editors. The blood-brain barrier cellular and molecular biology, New York: Raven Press.
37. Pinkofsky HB, Dwyer DS, Bradley RJ. 2000. The inhibition of GLUT1 glucose transport and cytochalasin B binding activity by tricyclic antidepressants. Life Sci 66:271-278.
38. Salah KM, Hampton KK, Findlay JB. 1982. The effect of general anaesthetics on glucose and phosphate transport across the membrane of the human erythrocyte. Biochim Biophys Acta 688:163-168.
39. Seidner G, Alvarez MG, Yeh JI, O'Driscoll KR, Klepper J, Stump TS, Wang D, Spinner NB, Birnbaum MJ, De Vivo DC. 1998. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 18:188-191.
40. Stephenson KN, Croxen RL, El-Barbary A, Fenstermacher JD, Haspel HC. 2000. Inhibiton of glucose transport and direct interaction with type 1 facultative glucose transproter (GLUT1) by etomidate, ketamine, and propofol: A comparison with barbiturates. Biochem Pharmacol 60:651-659.
41. Vera JC, Reyes AM, Carcamo JG, Velasquez FV, Rivas CI, Zhang RH, Strobel P, Iribarren R, Scher HI, Slebe JC, Golde DW. 1996. Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter, Glut1. J Biol Chem 271:8719-8724.
42. Vera JC, Reyes AM, Velasquez FV, Rivas CI, Zhang RH, Strobel P, Siebe JC, Nunez-Alarcon J, Golde DW. 2001. Direct inhibition of hexose transporter GLUT1 by tyrosine kinase inhibitors. Biochemistry 40:777-790.
43. Wagstaff P, Kang HY, Mylott D, Robbins PJ, White MK. 1995. Characterization of the avian GLUT1 glucose transporter: Differential regulation of GLUT1 and GLUT3 in chicken embryo fibroblasts. Mol Biol Cell 6:1575-1589.
44. Warner A, Privitera M, Bates D. 1998. Standards of laboratory practice: Antiepileptic drug monitoring. Clin Chem 44:1085-1095.
45. Wellner M, Mueckler MM, Keller K. 1993. GTP analogs suppress uptake but not transport of D-glucose analogs in GLUT1 glucose transporter-expressing Xenopus occytes. FEBS Lett 327:95-98.
46. Wong HY, Chu TS, Chan YW, Fok TF, Fung LW, Fung KP, Ho YY. 2005. The effects of phenytoin and its metabolite 5-(4-hydroxyphenyl)-5-phenylhydantoin on cellular glucose transport. Life Sci 76:1859-1872.
47. Yu S, Ding WG. 1998. The 45 kDa form of glucose transport 1 (GLUT1) is localized in oligodendrocyte and astrocyte but not in microglia in the rat brain. Brain Res 797:65-72.